Abacus Global authorizes new $100M share repurchase program
Board authorization effective August 17, 2026; builds on $80M repurchased since December 2023
What the filing says
Abacus Global Management, Inc. (NYSE: ABX) announced that its Board of Directors has authorized a $100 million share repurchase program, effective August 17, 2026. The program aligns with the Company's capital allocation framework and follows approximately $80 million in common stock repurchases executed under prior authorized programs since December 2023.
The Company expects to fund the repurchase program through ongoing free cash flow generation, proceeds from balance sheet transactions, and cash on hand. According to CEO Jay Jackson, the authorization reflects confidence in the Company's business model, its position in longevity-linked finance, and its ability to generate attractive returns on capital. The capital allocation strategy is designed to balance continued investment in origination growth, technology, and acquisitions with shareholder capital returns.
Execution mechanism and authorization details were not specified in the filing beyond the $100 million dollar authorization and the August 17, 2026 commencement date.
Abacus Global Management, Inc. ("Abacus" or the "Company") (NYSE: ABX), a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services with a focus on longevity-based assets and personalized financial planning, today announced that its Board of Directors has authorized a $100 million share repurchase program, commencing August 17, 2026. — Abacus Global Management, Inc. 8-K filing · View on SEC EDGAR →
What this means
The $100 million authorization represents a new capital allocation initiative for Abacus and builds on $80 million in repurchases completed under prior programs since December 2023, demonstrating a pattern of returning capital to shareholders. The filing does not disclose the execution mechanism (Rule 10b-18 open-market purchases, 10b5-1 plan, or other) or specific share-count targets. Combined with the prior $80 million, total authorized repurchases since late 2023 now reach $180 million. The company frames the program as complementary to growth investments in origination, technology, and M&A, rather than as a substitute for those priorities.</what_this_means> <parameter name="faqs">[ { "question": "When does Abacus's new $100 million repurchase program begin?", "answer": "The program commences on August 17, 2026, as announced in the 8-K filing dated August 13, 2026. The authorization was granted by the Company's Board of Directors." }, { "question": "How much stock has Abacus repurchased in the past?", "answer": "Abacus has repurchased approximately $80 million of common stock under prior authorized programs since December 2023. The new $100 million authorization builds on that track record of capital returns." }, { "question": "How will Abacus fund the $100 million repurchase program?", "answer": "The Company expects to fund the program through ongoing free cash flow generation, proceeds from balance sheet transactions, and cash on hand. The filing does not specify the execution mechanism or timing." }, { "question": "Does the buyback authorization limit other capital allocation priorities?", "answer": "No. Management stated that the capital allocation strategy is designed to balance continued investment in origination growth, technology, and acquisitions with share repurchases. The buyback is presented as complementary to, not in place of, growth initiatives." }, { "question": "What is the authorization amount in shares versus dollars?", "answer": "The filing authorizes the program on a dollar basis: $100 million total. No specific share-count authorization was disclosed in the 8-K announcement." }, { "question": "Why is Abacus repurchasing stock at this time?", "answer": "CEO Jay Jackson stated the authorization reflects confidence in the Company's business model, its position in longevity-linked finance, and its ability to generate attractive returns on capital. Management views the timing as aligned with the company's strategic vision and capital allocation framework." } ]